Potential correlation between anti-laminin 332 autoantibodies and malignant tumours in anti-BP180-type mucous membrane pemphigoid-Reference-Cited by-同舟云学术

Potential correlation between anti-laminin 332 autoantibodies and malignant tumours in anti-BP180-type mucous membrane pemphigoid

Published:2024-04-18 Issue:9 Volume:49 Page:1075-1076
ISSN:0307-6938
Container-title:Clinical and Experimental Dermatology
language:en
Short-container-title:

Author:

Li Xiaoguang¹,Pas Hendri H²,Qian Hua¹,Rashid Hanan²,Horvath Barbara²,Yilmaz Kaan³⁴,van Beek Nina³,Schmidt Enno³⁵^ORCID,Zillikens Detlef³,Ishii Norito⁶,Tsuruta Daisuke⁷,Hashimoto Takashi⁷

Affiliation:

1. School of Public Health and Laboratory Medicine, Hunan University of Medicine , Huaihua , China

2. Center for Blistering Diseases, Department of Dermatology, University Medical Center Groningen, University of Groningen , Groningen , the Netherlands

3. Department of Dermatology, University of Lübeck , Lübeck , Germany

4. Department of Dermatology, University of Heidelberg, Medical Faculty Mannheim , Mannheim , Germany

5. Lübeck Institute of Experimental Dermatology, University of Lübeck , Lübeck , Germany

6. Department of Dermatology, Kurume University School of Medicine , Kurume , Japan

7. Department of Dermatology, Graduate School of Medicine, Osaka Metropolitan University , Osaka , Japan

Abstract

To the best of our knowledge, this is the first large cohort study to analyse the potential correlations between anti-laminin (LM) 332 autoantibodies and malignant tumours in 520 patients with anti-BP180-type mucous membrane pemphigoid (BP180-MMP) recruited from four countries in two continents. Patients who were anti-LM332 autoantibody (–) with BP180-MMP were used as a control group. The results in this study support that anti-LM332 autoantibodies are positively correlated with malignant tumours in people with BP180-MMP, particularly in Europe.

Funder

JSPS KAKENHI

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/ced/advance-article-pdf/doi/10.1093/ced/llae124/58011083/llae124.pdf

Reference5 articles.

1. Clinical and immunological findings in 55 patients with anti-laminin 332-type mucous membrane pemphigoid;Li;Br J Dermatol,2021

2. A sensitive and specific assay for the serological diagnosis of antilaminin 332 mucous membrane pemphigoid;Goletz;Br J Dermatol,2019

3. Clinical and immunological studies of 332 Japanese patients tentatively diagnosed as anti-BP180-type mucous membrane pemphigoid: a novel BP180 C-terminal domain enzyme-linked immunosorbent assay;Yasukochi;Acta Derm Venereol,2016

4. comparison of two diagnostic assays for anti-laminin 332 mucous membrane pemphigoid;Goletz;Front Immunol,2021

5. Anti-laminin 332-type mucous membrane pemphigoid;Shi;Biomolecules,2022